These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 2869480

  • 1. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine.
    Donald IP, Wilkinson SP.
    Postgrad Med J; 1985 Dec; 61(722):1047-8. PubMed ID: 2869480
    [Abstract] [Full Text] [Related]

  • 2. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
    Rachmilewitz D.
    BMJ; 1989 Jan 14; 298(6666):82-6. PubMed ID: 2563951
    [Abstract] [Full Text] [Related]

  • 3. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
    Nakshabendi IM, Duncan A, Russell RI.
    Postgrad Med J; 1992 Mar 14; 68(797):189-91. PubMed ID: 1350343
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis.
    Dew MJ, Ebden P, Kidwai NS, Lee G, Evans BK, Rhodes J.
    Br J Clin Pharmacol; 1984 Apr 14; 17(4):474-6. PubMed ID: 6144318
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan 14; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution.
    Riley SA, Lecarpentier J, Mani V, Goodman MJ, Mandal BK, Turnberg LA.
    Gut; 1987 Aug 14; 28(8):1008-12. PubMed ID: 2889648
    [Abstract] [Full Text] [Related]

  • 20. [Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects].
    Dölle W, Daiss W.
    Verh Dtsch Ges Inn Med; 1988 Aug 14; 94():184-91. PubMed ID: 2905099
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.